

In November 2023, the Office of the Australian Information Commissioner (OAIC) announced the commencement of civil penalty proceedings against Australian Clinical Labs Limited (ACL), over a data breach that affected 223,000 Australians.
Proceedings were commenced only a week after the OAIC’s regulatory actions (in particular, its lack thereof) were criticised in Senate Estimates. This is only the second time the OAIC has used its civil penalty powers, granted in 2012. It’s also the first time the OAIC has taken action based on a failure of security (including delay in notifying of the breach). This should be an interesting one folks!

ACL is an ASX-listed company, which acquired Medlab Pathology in 2021. Medlab Pathology collects millions of individual patients’ health information as well as other personal identifying and contact information to share test results and issue invoices. This also includes copies of Medicare cards and numbers.
ACL generated revenue of $995.6 million in the financial year ending June 2022.
MedLab Pathology had a data breach in February 2023, but only notified the Office of the Australian Information Commissioner (OAIC) on 10 July 2022, some five months after it occurred.
ACL disclosed the data breach to the ASX in late October 2022, stating that the information of around 223,000 individuals had been affected, including personal information, sensitive health information and credit card information.
The OAIC kicked off a Commissioner-initiated investigation into the data breach in December 2022. The proceedings are a result of that investigation.
In response to the news, ACL has said it will be “defending the [OAIC’s] claim and asserts that its cyber security systems are robust”.

According to the OAIC’s statement, the OAIC believes that:
… from May 2021 to September 2022, ACL seriously interfered with the privacy of millions of Australians by failing to take reasonable steps to protect their personal information from unauthorised access or disclosure in breach of the Privacy Act 1988.
The Commissioner also alleges that following the data breach, ACL failed to carry out a reasonable assessment of whether it amounted to an eligible data breach and then failed to notify the Commissioner as soon as practicable.
In particular, the AIC alleges breaches of following provisions of the Privacy Act:
The Commissioner states that these failures left ACL vulnerable to cyberattack. The OAIC said: As a result of their information being on the dark web, individuals were exposed to potential emotional distress and the material risk of identity theft, extortion and financial crime.

Under section 13G of the Privacy Act, an organisation will be liable for a civil penalty if it does an act, or engages in a practice, that is a serious interference with the privacy of an individual.
However, under current legislation, the OAIC is unable to impose a civil penalty directly. For the penalty to apply, the OAIC must commence proceedings in the Federal Court, requesting that court to make a civil penalty order.
The Federal Court can impose a civil penalty of up to $2,220,000 for each contravention.
Following the Optus, Medibank and Latitude breaches last year, the Privacy Act was amended to, among other things, raise the maximum penalty amount. As of December 2022, the new maximum civil penalties for a serious and/or repeated interference are the greater of:
These new penalties will not be applicable to these proceedings.

In its response to the Privacy Act review report, the Australian Government agreed that section 13G of the Privacy Act, which deals with ‘serious or repeated’ breaches of privacy, should be amended to remove the word ‘repeated’ and clarify that a ‘serious’ interference can include repeated interferences with privacy (without those interferences necessarily being of themselves serious).
A new mid-tier civil penalty provision to cover interferences with privacy that do not meet the threshold of being ‘serious’ and a new low-level civil penalty provision for specific administrative breaches of the Privacy Act and APPs should be introduced. For these penalties, the OAIC will be empowered to issue infringement notices with set penalties.
Although there is no doubt that increased penalty powers will encourage privacy compliance, the OAIC has not had a great track record in using the powers that it has been given.
In recent Senate Estimates Hearings, Greens Senator David Shoebridge noted that the OAIC had been notified of 1,748 data breaches in the last two financial years but “not a single penalty has been issued”. In response, the AIC said the office has worked to ensure the purpose of the notifiable data breaches scheme has been achieved, “which is that individuals are notified [so] that they can take steps to mitigate their risk”. She also confirmed that investigations had been undertaken but that ‘(t)hey’ve been resolved by means other than by penalties.’ Ms Falk also referred to current major major investigations underway, ‘which is a result of specific funding that has enabled that kind of regulatory activity and has been very welcome.’ This is a reference to the Optus data breach funding which was included as a specific allocation in the most recent budget.
It is also no doubt a recognition that the OAIC has not been funded or resourced to undertake investigations into complex data breach cases, or to take the action required to pursue penalties in those cases, where that might be justified.
The outcome of these proceedings, and the Optus, Medibank and Latitude Finance data breach investigations, and in particular whether any penalties will be sought, will be watched with interest.
The ACL proceedings will also be of immense importance as the first case in which the question of what are reasonable steps to secure personal information for the purposes of APP 11 has been judicially considered.
Further resources:
OAIC commences Federal Court proceedings against Australian Clinical Labs Limited | OAIC
https://www.oaic.gov.au/newsroom/oaic-opens-investigation-into-medlab-over-data-breach
https://www.innovationaus.com/oaic-takes-pathology-company-to-court-over-data-breach/
"*" indicates required fields
"*" indicates required fields
Privacy 108 collects your name and email to send you our newsletter. If you do not provide this information, we will be unable to send it to you. We may use third-party service providers (such as email marketing platforms) to distribute our communications. Some providers may store information overseas, including in the United States. For more information about how we handle your personal information, including how to access or correct it or make a complaint, please see our Privacy Policy or contact us at hello@privacy108.com.au. You can unsubscribe at any time using the link in our emails or by contacting hello@privacy108.com.au.